PT Millennium Pharmacon International Tbk (ISX:SDPC) Total Operating Expense: Rp250,945 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SDPC PT Millennium Pharmacon International Tbk ISX:SDPC
79 GF Score
Price Rp181.00
GF Value Rp166.83
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PT Millennium Pharmacon International Tbk Total Operating Expense?

PT Millennium Pharmacon International Tbk ISX:SDPC 79 Total Operating Expense is Rp250,945 Mil as of Mar. 2026. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp166.83 (Fairly Valued). The stock has 5 warning signs investors should review.

PT Millennium Pharmacon International Tbk's Total Operating Expense for the three months ended in Mar. 2026 was Rp59,443 Mil. PT Millennium Pharmacon International Tbk's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was Rp250,945 Mil.


PT Millennium Pharmacon International Tbk Total Operating Expense Related Terms


PT Millennium Pharmacon International Tbk Total Operating Expense Historical Data

* Premium members only.

The historical data trend for PT Millennium Pharmacon International Tbk's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Millennium Pharmacon International Tbk Total Operating Expense Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 185,776.87 191,737.68 186,948.37 237,943.33 248,821.89

PT Millennium Pharmacon International Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57,319.62 56,588.10 60,013.46 74,900.71 59,442.89
ISX:SDPC
79GF Score
PT Millennium Pharmacon International Tbk ISX:SDPC
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Millennium Pharmacon International Tbk Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp250,945 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of Rp250,945 Mil mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a Total Operating Expense of Rp250,945 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on PT Millennium Pharmacon International Tbk and its competitors.
Is PT Millennium Pharmacon International Tbk's Total Operating Expense too high?
PT Millennium Pharmacon International Tbk's current Total Operating Expense is Rp250,945 Mil. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's Total Operating Expense compare to MCK and COR?
PT Millennium Pharmacon International Tbk's Total Operating Expense of Rp250,945 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Distribution company?
A good Total Operating Expense depends on the Medical Distribution industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on PT Millennium Pharmacon International Tbk and its competitors. PT Millennium Pharmacon International Tbk's current Total Operating Expense is Rp250,945 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current Total Operating Expense is Rp250,945 Mil. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current Total Operating Expense is Rp250,945 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued. The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83. GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.

Key valuation signals for ISX:SDPC:

  • Total Operating Expense: Rp250,945 Mil
  • GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Millennium Pharmacon International Tbk Business Description

Address Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score

Get the complete analysis for ISX:SDPC

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp181.00
Price
Rp166.83
GF Value